Solid Biosciences Announces Preliminary SGT-001 Data and Intention to Dose Escalate in IGNITE DMD Clinical Trial for Duchenne Muscular Dystrophy
Stock Information for Solid Biosciences Inc.
Loading
Please wait while we load your information from QuoteMedia.